Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine

被引:27
作者
Corazza, M [1 ]
Zampino, MR [1 ]
Montanari, A [1 ]
Altieri, E [1 ]
Virgili, A [1 ]
机构
[1] Univ Ferrara, Dipartimento Med Clin & Sperimentale, Sez Dermatol, I-44100 Ferrara, Italy
关键词
cyclosporine; psoriasis; lymphoma;
D O I
10.1159/000069946
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
We report the case of a 61-year-old woman who developed an anaplastic CD30+ cutaneous T-cell lymphoma during oral cyclosporine (CsA) therapy for recalcitrant psoriasis. Two months after CsA discontinuation, clinical and histological resolution of the lymphoma was observed. However, 3 years later extracutaneous involvement of the lymphoma could be detected. The association between CsA administration and the occurrence of the lymphoma may be casual, but a relationship with immunosuppression may also be hypothesized. We have reviewed all relevant data in the literature. To our knowledge, this is the first case of primary cutaneous CD30+ anaplastic large T-cell lymphoma in a patient treated with CsA for psoriasis.
引用
收藏
页码:330 / 333
页数:4
相关论文
共 21 条
[1]
Primary and secondary cutaneous CD30+ lymphoproliferative disorders:: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment [J].
Bekkenk, MW ;
Geelen, FAMJ ;
Vader, PCV ;
Heule, F ;
Geerts, ML ;
van Vloten, WA ;
Meijer, CJLM ;
Willemze, R .
BLOOD, 2000, 95 (12) :3653-3661
[2]
Boubenider S, 1997, J NEPHROL, V10, P136
[3]
Cliff S, 1999, BRIT J DERMATOL, V140, P763
[4]
THE RISK OF NEOPLASMS IN PATIENTS TREATED WITH CYCLOSPORINE-A [J].
COCKBURN, ITR ;
KRUPP, P .
JOURNAL OF AUTOIMMUNITY, 1989, 2 (05) :723-731
[5]
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens [J].
Dantal, J ;
Hourmant, M ;
Cantarovich, D ;
Giral, M ;
Blancho, G ;
Dreno, B ;
Soulillou, JP .
LANCET, 1998, 351 (9103) :623-628
[6]
The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30(+) lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin [J].
DeCoteau, JF ;
Butmarc, JR ;
Kinney, MC ;
Kadin, ME .
BLOOD, 1996, 87 (08) :3437-3441
[7]
Long-term safety of cyclosporine in the treatment of psoriasis [J].
Grossman, RM ;
Chevret, S ;
AbiRached, J ;
Blanchet, F ;
Dubertret, L .
ARCHIVES OF DERMATOLOGY, 1996, 132 (06) :623-629
[8]
Koo J, 1999, J AM ACAD DERMATOL, V40, P1016
[9]
THE DEVELOPMENT OF B-CELL LYMPHOMA IN A PATIENT WITH PSORIASIS TREATED WITH CYCLOSPORINE [J].
KOO, JY ;
KADONAGA, JN ;
WINTROUB, BV ;
LOZADANUR, FI .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (05) :836-840
[10]
SIDE-EFFECT PROFILE OF CYCLOSPORINE-A IN PATIENTS TREATED FOR PSORIASIS [J].
KRUPP, P ;
MONKA, C .
BRITISH JOURNAL OF DERMATOLOGY, 1990, 122 :47-56